Strathclyde Institute of Pharmacy & Biomedical Sciences, Glasgow, Scotland, United Kingdom.
Curr Protoc. 2021 Apr;1(4):e78. doi: 10.1002/cpz1.78.
Streptozotocin (STZ) is an antibiotic that causes pancreatic islet β-cell destruction and is widely used experimentally to produce a model of type 1 diabetes mellitus (T1DM). Detailed in this article are protocols for producing STZ-induced insulin deficiency and hyperglycemia in mice and rats. Also described are protocols for creating animal models for type 2 diabetes using STZ. These animals are employed for assessing the pathological consequences of diabetes and for screening potential therapies for the treatment of this condition. © 2021 The Authors.
链脲佐菌素(STZ)是一种抗生素,可导致胰岛β细胞破坏,广泛用于实验性诱导 1 型糖尿病(T1DM)模型。本文详细介绍了在小鼠和大鼠中诱导 STZ 引起的胰岛素缺乏和高血糖的方案。还描述了使用 STZ 建立 2 型糖尿病动物模型的方案。这些动物用于评估糖尿病的病理后果,并筛选治疗该疾病的潜在疗法。© 2021 作者。